Publication Name	World Journal of Clinical Cases
Manuscript ID	84975
Country	China

Received	2023-04-05 12:22
Peer-Review Started	2023-04-05 12:24
First Decision by Editorial Office Director	2023-05-19 02:16
Return for Revision	2023-05-19 02:16
Revised	2023-05-30 12:59
Publication Fee Transferred
Second Decision by Editor	2023-07-04 02:48
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director	2023-07-04 08:52
Articles in Press	2023-07-04 08:52
Edit the Manuscript by Language Editor	2023-06-25 13:45
Typeset the Manuscript	2023-07-27 07:44
Publish the Manuscript Online	2023-08-03 10:22

ISSN	2307-8960 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Rheumatology
Manuscript Type	Case Report
Article Title	Treatment of refractory anti-melanoma differentiation-associated gene 5 anbibody-positive dermatomyositis complicated by rapidly progressing interstitial pulmonary disease: Two case reports
Manuscript Source	Unsolicited Manuscript
All Author List	Qiao-Hong Wang and Li-Heng Chen
Funding Agency and Grant Number
Corresponding Author	Qiao-Hong Wang, MS, Associate Chief Physician, Department of Rheumatology, Second Affiliated Hospital, College of Medicine, Zhejiang University, No. 88 Jiefang Road, Hangzhou 310009, Zhejiang Province, China. 2202015@zju.edu.cn
Key Words	Anti-melanoma differentiation-associated gene 5 antibody-positive; Dermatomyositis; Progressive interstitial lung disease; Interstitial lung disease; Tocilizumab; Case report
Core Tip	The early detection of myositis-related antibody profile and its concentration together with serum ferritin and cytokine levels is key to the clinical diagnosis and prognosis of anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis complicated with rapidly progressive interstitial lung disease (anti-MDA5 Ab+ DM-RP-ILD). For patients with anti-MDA5 Ab+ DM-RP-ILD refractory to intensive immunosuppression, tocilizumab could be a salvage treatment.
Publish Date	2023-08-03 10:22
Citation	Wang QH, Chen LH. Treatment of refractory anti-melanoma differentiation-associated gene 5 anbibody-positive dermatomyositis complicated by rapidly progressing interstitial pulmonary disease: Two case reports. World J Clin Cases 2023; 5351-5357
URL	https://www.wjgnet.com/2307-8960/full/v11/i22/5351.htm
DOI	https://dx.doi.org/10.12998/wjcc.v11.i22.5351

Full Article (PDF)	WJCC-11-5351-with-cover.pdf
Full Article (Word)	WJCC-11-5351.docx
Manuscript File	84975_Auto_Edited-CL-WangTQ-JLW.docx
Answering Reviewers	84975-Answering reviewers.pdf
Audio Core Tip	84975-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	84975-Conflict-of-interest statement.pdf
Copyright License Agreement	84975-Copyright license agreement.pdf
Signed Consent for Treatment Form(s) or Document(s)	84975-Informed consent statement.pdf
Non-Native Speakers of English Editing Certificate	84975-Language certificate.pdf
Peer-review Report	84975-Peer-review(s).pdf
Scientific Misconduct Check	84975-Bing-Lin C-2.png
Scientific Editor Work List	84975-Scientific editor work list.pdf
CrossCheck Report	84975-CrossCheck.png
CrossCheck Report	84975-CrossCheck report.pdf